Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study.

Authors :: Avallone G
Mastorino L
Tavoletti G
Macagno N
Barei F
Schena D
Rossi M
Magnaterra E
Antonelli F
Babino G
Viola R
Gargiulo L
Conforti C
Rapparini L
Errichetti E
Patruno C
Ruggiero P
Roccuzzo G
Maronese CA
Girolomoni G
Gola M
Chiricozzi A
Balato A
Ambrogio F
Narcisi A
Zalaudek I
Gurioli C
Napolitano M
Marzano AV
Foti C
Costanzo A
Piraccini BM
Ferrucci SM
Ortoncelli M
Quaglino P
Ribero S
Source :: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 May; Vol. 90 (5), pp. 1031-1034. Date of Electronic Publication: 2024 Jan 09.
Publication Year :: 2024
Abstract: Competing Interests: Conflicts of interest None disclosed.

Subjects :: Humans
Retrospective Studies
Treatment Outcome
Janus Kinase Inhibitors adverse effects
Dermatitis, Atopic drug therapy
Acne Vulgaris drug therapy
Heterocyclic Compounds, 3-Ring

Full Text Access

Tools